Technical Analysis for AVCT - Avacta Group Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Multiple of Ten Bullish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| NR7 | Range Contraction | 1.64% | |
| Multiple of Ten Bearish | Other | 1.64% | |
| Wide Bands | Range Expansion | 1.64% | |
| 180 Bullish Setup | Bullish Swing Setup | 4.61% | |
| Multiple of Ten Bullish | Other | 4.61% | |
| Wide Bands | Range Expansion | 4.61% | |
| Gapped Up | Strength | 4.61% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 3x Volume Pace | 2 days ago |
| 2x Volume Pace | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| Rose Above Previous Day's High | 2 days ago |
| Up 3% | 2 days ago |
Get a Trading Sidekick!
Avacta Group Plc Description
Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Science Medicine Tools Life Sciences Clinic Branches Of Biology Medical Specialties Oncology Immunology Immune System Antibodies Assay Disorders Aptamer Synthetic Antibody
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 168.0 |
| 52 Week Low | 38.0 |
| Average Volume | 2,020,644 |
| 200-Day Moving Average | 116.41 |
| 50-Day Moving Average | 125.65 |
| 20-Day Moving Average | 147.13 |
| 10-Day Moving Average | 153.35 |
| Average True Range | 9.32 |
| RSI | 63.90 |
| ADX | 33.64 |
| +DI | 30.00 |
| -DI | 13.17 |
| Chandelier Exit (Long, 3 ATRs) | 140.04 |
| Chandelier Exit (Short, 3 ATRs) | 148.96 |
| Upper Bollinger Bands | 171.84 |
| Lower Bollinger Band | 122.41 |
| Percent B (%b) | 0.78 |
| BandWidth | 33.59 |
| MACD Line | 8.88 |
| MACD Signal Line | 9.15 |
| MACD Histogram | -0.2699 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 173.78 | ||||
| Resistance 3 (R3) | 174.00 | 170.00 | 171.66 | ||
| Resistance 2 (R2) | 170.00 | 166.77 | 169.89 | 170.96 | |
| Resistance 1 (R1) | 165.55 | 164.78 | 167.78 | 165.33 | 170.25 |
| Pivot Point | 161.55 | 161.55 | 162.66 | 161.44 | 161.55 |
| Support 1 (S1) | 157.10 | 158.32 | 159.33 | 156.88 | 151.95 |
| Support 2 (S2) | 153.10 | 156.33 | 152.99 | 151.24 | |
| Support 3 (S3) | 148.65 | 153.10 | 150.54 | ||
| Support 4 (S4) | 148.43 |
